Doliff-BTR Tablet
By Doliff-BTR
Rx
10 Tablet in a Strip

Composition
Trypsin(48mg) + Bromelain(90mg) + Rutoside(100mg) + Diclofenac(50mg)

Manufacturer - Elcliff Formulations Pvt Ltd
SCO 9, District Sub Center, TDL complex, Yamuna Nagar, Haryana – 135001 , India.

Expires on or after
September, 2025

liver
Doliff-BTR Tablet is generally considered safe for use in individuals with liver disease. The available data indicates that there may not be a requirement to adjust the dosage of Doliff-BTR Tablet for patients with liver issues. It is recommended to discuss any concerns or questions you may have with your healthcare provider before using this medication.

kidney
Limited data suggests that Doliff-BTR Tablet is likely safe for use in patients with kidney disease. Consult your doctor for guidance as dose adjustment may not be necessary.

alcohol
When taking Doliff-BTR Tablet, it is uncertain if it is safe to drink alcohol. It's best to consult with your doctor for personalized advice.

driving
Caution - Driving Doliff-BTR Tablet may cause headaches, blurred vision, dizziness, or drowsiness, affecting your driving ability.

pregnancy
Doliff-BTR Tablet should be avoided during pregnancy due to potential risks to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using Doliff-BTR Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹210
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024